Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

TPO-mimetics and myelofibrosis? A reticulin question!

Lambert MP.

Blood. 2009 Oct 29;114(18):3722-3. doi: 10.1182/blood-2009-09-239863. No abstract available.

2.
3.

Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.

Wagner-Ballon O, Chagraoui H, Prina E, Tulliez M, Milon G, Raslova H, Villeval JL, Vainchenker W, Giraudier S.

J Immunol. 2006 Jun 1;176(11):6425-33.

4.

Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.

Kakumitsu H, Kamezaki K, Shimoda K, Karube K, Haro T, Numata A, Shide K, Matsuda T, Oshima K, Harada M.

Leuk Res. 2005 Jul;29(7):761-9. Epub 2005 Mar 2.

PMID:
15927672
5.

Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.

Colović MD, Wiernik PH, Janković GM, Vidović AD, Janosević S, Basara NM.

Eur J Haematol. 1999 Mar;62(3):155-9.

PMID:
10089892
6.

[Reversible reticulin myelofibrosis associated with pernicious anemia].

Ribera JM, Bladé J, Brugués R, Vives Corrons JL, Rozman C.

Sangre (Barc). 1985;30(3):369-71. Spanish. No abstract available.

PMID:
4035529
7.

Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.

Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F.

Blood. 2002 Nov 15;100(10):3495-503. Epub 2002 Jul 5.

8.

Vitamin D-deficiency rickets and myelofibrosis.

Yetgin S, Ozsoylu S, Ruacan S, Tekinalp G, Sarialioğlu F.

J Pediatr. 1989 Feb;114(2):213-7.

PMID:
2536807
9.

Biochemical and histological analysis of bone marrow collagen in myelofibrosis.

Charron D, Robert L, Couty MC, Binet JL.

Br J Haematol. 1979 Feb;41(2):151-61.

PMID:
427028
10.

Myelofibrosis in chronic granulocytic leukaemia.

Clough V, Geary CG, Hashmi K, Davson J, Knowlson T.

Br J Haematol. 1979 Aug;42(4):515-26.

PMID:
289409
11.

Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.

Thiele J, Kvasnicka HM, Beelen DW, Pilgram B, Rose A, Leder LD, Schaefer UW.

Leukemia. 2000 Aug;14(8):1378-85.

PMID:
10942232
12.

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.

Evrard S, Bluteau O, Tulliez M, Rameau P, Gonin P, Zetterberg E, Palmblad J, Bonnefoy A, Villeval JL, Vainchenker W, Giraudier S, Wagner-Ballon O.

Blood. 2011 Jan 6;117(1):246-9. doi: 10.1182/blood-2010-07-294447. Epub 2010 Oct 13.

13.

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.

Barosi G.

Best Pract Res Clin Haematol. 2014 Jun;27(2):129-40. doi: 10.1016/j.beha.2014.07.004. Epub 2014 Jul 18. Review.

PMID:
25189724
14.

Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.

Ohsaka A, Miura Y, Takahashi A, Yokoyama T.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(6):399-405.

PMID:
1683056
15.

The reticulin content of bone marrow in haematological disorders.

BURSTON J, PINNIGER JL.

Br J Haematol. 1963 Apr;9:172-84. No abstract available.

PMID:
14017214
18.
19.

The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia.

Dekmezian R, Kantarjian HM, Keating MJ, Talpaz M, McCredie KB, Freireich EJ.

Cancer. 1987 May 15;59(10):1739-43.

Supplemental Content

Support Center